{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T04:54:53Z","timestamp":1790139293953,"version":"4.0.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007914","name":"The University of Texas Southwestern Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007914","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","redjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ijrobp.2024.07.2147","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T12:27:59Z","timestamp":1721478479000},"page":"137-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR Trial"],"prefix":"10.1016","volume":"121","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3943-7480","authenticated-orcid":false,"given":"David J.","family":"Sher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Avkshtol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dat","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ted","family":"Mau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Childs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mu-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Dubas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chul","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baran D.","family":"Sumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0001","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx042","article-title":"Hypofractionated radiotherapy for patients with early-stage glottic cancer: Patterns of care and survival","volume":"109","author":"Bledsoe","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0002","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/lary.27873","article-title":"Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation","volume":"130","author":"Mohamed","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0003","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ijrobp.2023.04.035","article-title":"Intensity modulated radiation therapy for early stage squamous cell carcinoma of the glottic larynx: A systematic review and meta-analysis","volume":"117","author":"Razavian","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0004","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2015.06.016","article-title":"Single vocal cord irradiation: Image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: Early clinical results","volume":"93","author":"Al-Mamgani","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2022.105782","article-title":"Single vocal cord irradiation for early-stage glottic cancer: Excellent local control and favorable toxicity profile","volume":"127","author":"Tans","year":"2022","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0006","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2019.03.011","article-title":"Early closure of a phase 1 clinical trial for SABR in early-stage glottic cancer","volume":"105","author":"Kang","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0007","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2019.03.010","article-title":"Phase 1 fractional dose-escalation study of equipotent stereotactic radiation therapy regimens for early-stage glottic larynx cancer","volume":"105","author":"Sher","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0008","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.radonc.2020.08.027","article-title":"Surface guided motion management in glottic larynx stereotactic body radiation therapy","volume":"153","author":"Zhao","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0009","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","article-title":"T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy","volume":"78","author":"Chera","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1048242","article-title":"A single-arm study design with non-inferiority and superiority time-to-event endpoints: A tool for proof-of-concept and de-intensification strategies in breast cancer","volume":"13","author":"Sampayo-Cordero","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0011","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.otc.2022.12.008","article-title":"Radiation for early glottic cancer","volume":"56","author":"Schonewolf","year":"2023","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0012","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40463-021-00553-7","article-title":"Oncological and functional outcomes following treatment of T1a glottic squamous cell carcinoma with transoral laser microsurgery","volume":"51","author":"Curry","year":"2022","journal-title":"J Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0013","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1007\/s00405-023-07904-2","article-title":"Oncological outcome of vocal cord-only radiotherapy for cT1-T2 glottic laryngeal squamous cell carcinoma","volume":"280","author":"de Ridder","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0014","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1186\/s12885-021-08195-8","article-title":"Vocal-cord only vs. complete laryngeal radiation (VOCAL): A randomized multicentric Bayesian phase II trial","volume":"21","author":"Bahig","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1177\/03008916211000440","article-title":"Stereotactic body radiotherapy for T1 glottic cancer: Dosimetric data in 27 consecutive patients","volume":"107","author":"Sanguineti","year":"2021","journal-title":"Tumori"},{"key":"10.1016\/j.ijrobp.2024.07.2147_bib0016","unstructured":"Phase II randomized study of hypofractionated versus conventional radiotherapy (G-FORCE). ClinicalTrials.gov identifier: NCT06080503. Updated May 8, 2024. Accessed XXX. https:\/\/clinicaltrials.gov\/study\/NCT06080503"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624029729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301624029729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T19:33:38Z","timestamp":1741635218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301624029729"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S0360301624029729"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.07.2147","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Ablative Radiotherapy for T1 to T2 Glottic Larynx Cancer: Mature Results From the Phase 2 GLoTtic Larynx-SABR Trial","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2024.07.2147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}